234
Views
3
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Association of Serum Bilirubin Levels with Macro- and Microvascular Complications in Chinese People with Type 2 Diabetes Mellitus: New Insight on Gender Differences

, , , , , & show all
Pages 597-606 | Received 03 Jan 2023, Accepted 28 Feb 2023, Published online: 04 Mar 2023

References

  • Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019;157:107843. doi:10.1016/j.diabres.2019.107843
  • Arnold SV, Khunti K, Tang F, et al. Incidence rates and predictors of microvascular and macrovascular complications in patients with type 2 diabetes: results from the longitudinal global discover study. Am Heart J. 2022;243:232–239. doi:10.1016/j.ahj.2021.10.181
  • Bhatti JS, Sehrawat A, Mishra J, et al. Oxidative stress in the pathophysiology of type 2 diabetes and related complications: current therapeutics strategies and future perspectives. Free Radic Biol Med. 2022;184:114–134. doi:10.1016/j.freeradbiomed.2022.03.019
  • Rohm TV, Meier DT, Olefsky JM, et al. Inflammation in obesity, diabetes, and related disorders. Immunity. 2022;55(1):31–55. doi:10.1016/j.immuni.2021.12.013
  • Magsi R, Shetty N, Giffen Z, et al. Serum bilirubin as a predictor of graft outcomes after renal transplant. Am J Clin Exp Urol. 2022;10(1):37–43.
  • Zhong P, Sun D, Wu D, et al. Total bilirubin is negatively related to diabetes mellitus in Chinese elderly: a community study. Ann Transl Med. 2019;7(18):474. doi:10.21037/atm.2019.07.104
  • Eto E, Maeda Y, Sonoda N, et al. Association of serum total bilirubin levels with progressive renal decline and end-stage kidney disease: 10-year observational cohort study in Japanese patients with diabetes. PLoS One. 2022;17(7):e0271179. doi:10.1371/journal.pone.0271179
  • Liu M, Wang J, He Y. The U-shaped association between bilirubin and diabetic retinopathy risk: a five-year cohort based on 5323 male diabetic patients. J Diabetes Res. 2018;2018:4603087. doi:10.1155/2018/4603087
  • Chen J, Wang J, Zhang X, et al. Inverse relationship between serum bilirubin levels and diabetic foot in chinese patients with Type 2 diabetes mellitus. Med Sci Monit. 2017;23:5916–5923. doi:10.12659/msm.907248
  • Liu M, Li Y, Li J, et al. Elevated serum total bilirubin levels are negatively associated with major diabetic complications among Chinese senile diabetic patients. J Diabetes Complications. 2017;31(1):213–217. doi:10.1016/j.jdiacomp.2016.08.023
  • Maric-Bilkan C. Sex differences in micro- and macro-vascular complications of diabetes mellitus. Clin Sci (Lond). 2017;131(9):833–846. doi:10.1042/CS20160998
  • Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539–553. doi:10.1002/(SICI)1096-9136(199807)15:7
  • The Japanese Society of Nephrology. Clinical Practice Guidebook for Diagnosis and Treatment of Chronic Kidney Disease. Jpn J Nephrol. 2012;54:1031–1189.
  • Yasu T. Comprehensive cardiac rehabilitation program for peripheral arterial diseases. J Cardiol. 2022;80(4):303–305. doi:10.1016/j.jjcc.2021.11.011
  • Zhao S, Yu S, Chi C, et al. Association between macro- and microvascular damage and the triglyceride glucose index in community-dwelling elderly individuals: the Northern Shanghai Study. Cardiovasc Diabetol. 2019;18(1):95. doi:10.1186/s12933-019-0898-x
  • Wen G, Yao L, Hao Y, et al. Bilirubin ameliorates murine atherosclerosis through inhibiting cholesterol synthesis and reshaping the immune system. J Transl Med. 2022;20(1):1. doi:10.1186/s12967-021-03207-4
  • Björkegren JLM, Lusis AJ. Atherosclerosis: recent developments. Cell. 2022;185(10):1630–1645. doi:10.1016/j.cell.2022.04.004
  • Yu F, Zhang L, Liao D, et al. Serum bilirubin levels and extent of symptomatic intracranial atherosclerotic stenosis in acute ischemic stroke: a cross-sectional study. Front Neurol. 2021;12:714098. doi:10.3389/fneur.2021.714098
  • Shi Y, Zhou W, Cheng M, et al. Association of plasma bilirubin levels with peripheral arterial disease in Chinese hypertensive patients: new insight on sex differences. Front Physiol. 2022;13:867418. doi:10.3389/fphys.2022.867418
  • Zuo L, Huang J, Zhang H, et al. Dose-response association between bilirubin and cardiovascular disease: a systematic review and meta-analysis. Angiology. 2022;73(10):911–919. doi:10.1177/00033197211059693
  • Lan Y, Liu H, Liu J, et al. The relationship between serum bilirubin levels and peripheral arterial disease and gender difference in patients with hypertension: BEST study. Angiology. 2020;71(4):340–348. doi:10.1177/0003319719900734
  • Fukui M, Tanaka M, Shiraishi E, et al. Relationship between serum bilirubin and albuminuria in patients with type 2 diabetes. Kidney Int. 2008;74(9):1197–1201. doi:10.1038/ki.2008.398
  • Katoh T, Kawamoto R, Kohara K, et al. Association between serum bilirubin and estimated glomerular filtration rate among diabetic patients. Int Sch Res Notices. 2015;2015:480418. doi:10.1155/2015/480418
  • Chen J, Liu Q, He J, et al. Immune responses in diabetic nephropathy: pathogenic mechanisms and therapeutic target. Front Immunol. 2022;13:958790. doi:10.3389/fimmu.2022.958790
  • Yang J, Liu Z. Mechanistic pathogenesis of endothelial dysfunction in diabetic nephropathy and retinopathy. Front Endocrinol (Lausanne). 2022;13:816400. doi:10.3389/fendo.2022.816400
  • Hussein MM, Mahfouz MK. Effect of resveratrol and rosuvastatin on experimental diabetic nephropathy in rats. Biomed Pharmacother. 2016;82:685–692. doi:10.1016/j.biopha.2016.06.004
  • Dugbartey GJ, Alornyo KK, Diaba DE, et al. Activation of renal CSE/H2S pathway by alpha-lipoic acid protects against histological and functional changes in the diabetic kidney. Biomed Pharmacother. 2022;153:113386. doi:10.1016/j.biopha.2022.113386
  • Baranano DE, Rao M, Ferris CD, et al. Biliverdin reductase: a major physiologic cytoprotectant. Proc Natl Acad Sci USA. 2002;99(25):16093–16098. doi:10.1073/pnas.252626999
  • Fujii M, Inoguchi T, Sasaki S, et al. Bilirubin and biliverdin protect rodents against diabetic nephropathy by downregulating NAD(P)H oxidase. Kidney Int. 2010;78(9):905–919. doi:10.1038/ki.2010.265
  • Tran DT, Jeong YY, Kim JM, et al. The anti-inflammatory role of bilirubin on “Two-Hit” sepsis animal model. Int J Mol Sci. 2020;21(22):8650. doi:10.3390/ijms21228650
  • Dekker D, Dorresteijn MJ, Pijnenburg M, et al. The bilirubin-increasing drug atazanavir improves endothelial function in patients with type 2 diabetes mellitus. Arterioscler Thromb Vasc Biol. 2011;31(2):458–463. doi:10.1161/ATVBAHA.110.211789
  • Silveira Rossi JL, Barbalho SM, Reverete de Araujo R, et al. Metabolic syndrome and cardiovascular diseases: going beyond traditional risk factors. Diabetes Metab Res Rev. 2022;38(3):e3502. doi:10.1002/dmrr.3502
  • Yardeni D, Toledano R, Novack V, et al. The association of alanine aminotransferase levels with myocardial perfusion imaging and cardiovascular morbidity. J Cardiovasc Pharmacol Ther. 2022;27:10742484221074585. doi:10.1177/10742484221074585
  • He S, Li Y, Li T, et al. Sex differences between serum total bilirubin levels and cognition in patients with schizophrenia. BMC Psychiatry. 2021;21(1):396. doi:10.1186/s12888-021-03407-8
  • Gerges SH, El-Kadi AOS. Sex differences in eicosanoid formation and metabolism: a possible mediator of sex discrepancies in cardiovascular diseases. Pharmacol Ther. 2022;234:108046. doi:10.1016/j.pharmthera.2021.108046
  • Wang M, Gan W, Kartsonaki C, et al. Menopausal status, age at natural menopause and risk of diabetes in China: a 10-year prospective study of 300,000 women. Nutr Metab. 2022;19(1):7. doi:10.1186/s12986-022-00643-x
  • Luo W, Gong L, Chen X, et al. Lifestyle and chronic kidney disease: a machine learning modeling study. Front Nutr. 2022;9:918576. doi:10.3389/fnut.2022.918576